Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Is there a duty to reinterpret genetic data? The ethical dimensions.

Appelbaum PS, Parens E, Berger SM, Chung WK, Burke W.

Genet Med. 2020 Mar;22(3):633-639. doi: 10.1038/s41436-019-0679-7. Epub 2019 Oct 15.

PMID:
31616070
2.

Chromosomal Heterogeneity of the G-401 Rhabdoid Tumor Cell Line: Unusual Partial 7p Trisomy.

Fasler-Kan E, Aliu N, Haecker FM, Maltsev N, Ruggiero S, Cholewa D, Bartenstein A, Milošević M, Berger SM.

Front Med (Lausanne). 2019 Aug 30;6:187. doi: 10.3389/fmed.2019.00187. eCollection 2019.

3.

Impact of patient education videos on genetic counseling outcomes after exome sequencing.

Hernan R, Cho MT, Wilson AL, Ahimaz P, Au C, Berger SM, Guzman E, Primiano M, Shaw JE, Ross M, Tabanfar L, Chilton I, Griffin E, Ratner C, Anyane-Yeboa K, Iglesias A, Pisani L, Roohi J, Duong J, Martinez J, Appelbaum P, Klitzman R, Ottman R, Chung WK, Wynn J.

Patient Educ Couns. 2020 Jan;103(1):127-135. doi: 10.1016/j.pec.2019.08.018. Epub 2019 Aug 24.

PMID:
31521424
4.

Pianp deficiency links GABAB receptor signaling and hippocampal and cerebellar neuronal cell composition to autism-like behavior.

Winkler M, Biswas S, Berger SM, Küchler M, Preisendörfer L, Choo M, Früh S, Rem PD, Enkel T, Arnold B, Komljenovic D, Sticht C, Goerdt S, Bettler B, von Bohlen Und Halbach O, Bartsch D, Géraud C.

Mol Psychiatry. 2019 Sep 11. doi: 10.1038/s41380-019-0519-9. [Epub ahead of print]

PMID:
31511635
5.

The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer.

Yasinska IM, Sakhnevych SS, Pavlova L, Teo Hansen Selnø A, Teuscher Abeleira AM, Benlaouer O, Gonçalves Silva I, Mosimann M, Varani L, Bardelli M, Hussain R, Siligardi G, Cholewa D, Berger SM, Gibbs BF, Ushkaryov YA, Fasler-Kan E, Klenova E, Sumbayev VV.

Front Immunol. 2019 Jul 11;10:1594. doi: 10.3389/fimmu.2019.01594. eCollection 2019.

6.

Highly specific targeting of human acute myeloid leukaemia cells using pharmacologically active nanoconjugates.

Yasinska IM, Ceccone G, Ojea-Jimenez I, Ponti J, Hussain R, Siligardi G, Berger SM, Fasler-Kan E, Bardelli M, Varani L, Fiedler W, Wellbrock J, Raap U, Gibbs BF, Calzolai L, Sumbayev VV.

Nanoscale. 2018 Mar 29;10(13):5827-5833. doi: 10.1039/c7nr09436a.

7.

Forebrain-specific, conditional silencing of Staufen2 alters synaptic plasticity, learning, and memory in rats.

Berger SM, Fernández-Lamo I, Schönig K, Fernández Moya SM, Ehses J, Schieweck R, Clementi S, Enkel T, Grothe S, von Bohlen Und Halbach O, Segura I, Delgado-García JM, Gruart A, Kiebler MA, Bartsch D.

Genome Biol. 2017 Nov 17;18(1):222. doi: 10.1186/s13059-017-1350-8.

8.

The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells.

Gonçalves Silva I, Yasinska IM, Sakhnevych SS, Fiedler W, Wellbrock J, Bardelli M, Varani L, Hussain R, Siligardi G, Ceccone G, Berger SM, Ushkaryov YA, Gibbs BF, Fasler-Kan E, Sumbayev VV.

EBioMedicine. 2017 Aug;22:44-57. doi: 10.1016/j.ebiom.2017.07.018. Epub 2017 Jul 19.

9.

Effects of p75NTR deficiency on cholinergic innervation of the amygdala and anxiety-like behavior.

Busch R, Baldus M, Vogt MA, Berger SM, Bartsch D, Gass P, von Bohlen Und Halbach O.

J Neurochem. 2017 May;141(3):461-471. doi: 10.1111/jnc.14006. Epub 2017 Apr 4.

10.

The immune receptor Tim-3 acts as a trafficker in a Tim-3/galectin-9 autocrine loop in human myeloid leukemia cells.

Gonçalves Silva I, Rüegg L, Gibbs BF, Bardelli M, Fruehwirth A, Varani L, Berger SM, Fasler-Kan E, Sumbayev VV.

Oncoimmunology. 2016 Jun 29;5(7):e1195535. doi: 10.1080/2162402X.2016.1195535. eCollection 2016 Jul.

11.

Associations between metabolic disorders and risk of cancer in Danish men and women--a nationwide cohort study.

Berger SM, Gislason G, Moore LL, Andersson C, Torp-Pedersen C, Denis GV, Schmiegelow MD.

BMC Cancer. 2016 Feb 22;16:133. doi: 10.1186/s12885-016-2122-7.

12.

mTORC1 directly phosphorylates and activates ERα upon estrogen stimulation.

Alayev A, Salamon RS, Berger SM, Schwartz NS, Cuesta R, Snyder RB, Holz MK.

Oncogene. 2016 Jul 7;35(27):3535-43. doi: 10.1038/onc.2015.414. Epub 2015 Nov 2.

13.

Caffeine affects the biological responses of human hematopoietic cells of myeloid lineage via downregulation of the mTOR pathway and xanthine oxidase activity.

Gibbs BF, Gonçalves Silva I, Prokhorov A, Abooali M, Yasinska IM, Casely-Hayford MA, Berger SM, Fasler-Kan E, Sumbayev VV.

Oncotarget. 2015 Oct 6;6(30):28678-92. doi: 10.18632/oncotarget.5212.

14.

Resveratrol as a novel treatment for diseases with mTOR pathway hyperactivation.

Alayev A, Berger SM, Holz MK.

Ann N Y Acad Sci. 2015 Aug;1348(1):116-23. doi: 10.1111/nyas.12829. Epub 2015 Jul 22. Review.

PMID:
26200935
15.

Impact of a deletion of the full-length and short isoform of p75NTR on cholinergic innervation and the population of postmitotic doublecortin positive cells in the dentate gyrus.

Poser R, Dokter M, von Bohlen Und Halbach V, Berger SM, Busch R, Baldus M, Unsicker K, von Bohlen Und Halbach O.

Front Neuroanat. 2015 May 27;9:63. doi: 10.3389/fnana.2015.00063. eCollection 2015.

16.

Impact of metabolic disorders on the relation between overweight/obesity and incident myocardial infarction and ischaemic stroke in fertile women: a nationwide cohort study.

Andersen SS, Andersson C, Berger SM, Jensen TB, Torp-Pedersen CT, Gislason GH, Køber L, Schmiegelow MD.

Clin Obes. 2015 Jun;5(3):127-35. doi: 10.1111/cob.12096. Epub 2015 Apr 15.

PMID:
25873234
17.

Adult AMPA GLUA1 receptor subunit loss in 5-HT neurons results in a specific anxiety-phenotype with evidence for dysregulation of 5-HT neuronal activity.

Weber T, Vogt MA, Gartside SE, Berger SM, Lujan R, Lau T, Herrmann E, Sprengel R, Bartsch D, Gass P.

Neuropsychopharmacology. 2015 May;40(6):1471-84. doi: 10.1038/npp.2014.332. Epub 2014 Dec 30.

18.

The combination of rapamycin and resveratrol blocks autophagy and induces apoptosis in breast cancer cells.

Alayev A, Berger SM, Kramer MY, Schwartz NS, Holz MK.

J Cell Biochem. 2015 Mar;116(3):450-7. doi: 10.1002/jcb.24997.

19.

Phosphoproteomics reveals resveratrol-dependent inhibition of Akt/mTORC1/S6K1 signaling.

Alayev A, Doubleday PF, Berger SM, Ballif BA, Holz MK.

J Proteome Res. 2014 Dec 5;13(12):5734-42. doi: 10.1021/pr500714a. Epub 2014 Oct 29.

20.

Time elapsed after ischemic stroke and risk of adverse cardiovascular events and mortality following elective noncardiac surgery.

Jørgensen ME, Torp-Pedersen C, Gislason GH, Jensen PF, Berger SM, Christiansen CB, Overgaard C, Schmiegelow MD, Andersson C.

JAMA. 2014 Jul 16;312(3):269-77. doi: 10.1001/jama.2014.8165.

PMID:
25027142
21.

The role of L-type voltage-gated calcium channels Cav1.2 and Cav1.3 in normal and pathological brain function.

Berger SM, Bartsch D.

Cell Tissue Res. 2014 Aug;357(2):463-76. doi: 10.1007/s00441-014-1936-3. Epub 2014 Jul 5. Review.

PMID:
24996399
22.

Reduced expression of the retinoblastoma protein shows that the related signaling pathway is essential for mediating the antineoplastic activity of erufosine.

Zaharieva MM, Kirilov M, Chai M, Berger SM, Konstantinov S, Berger MR.

PLoS One. 2014 Jul 2;9(7):e100950. doi: 10.1371/journal.pone.0100950. eCollection 2014.

23.
24.

Associations between body mass index and development of metabolic disorders in fertile women--a nationwide cohort study.

Schmiegelow MD, Andersson C, Køber L, Andersen SS, Norgaard ML, Jensen TB, Gislason G, Berger SM, Torp-Pedersen C.

J Am Heart Assoc. 2014 Apr 10;3(2):e000672. doi: 10.1161/JAHA.113.000672.

25.

Reduced expression of nogo-a leads to motivational deficits in rats.

Enkel T, Berger SM, Schönig K, Tews B, Bartsch D.

Front Behav Neurosci. 2014 Jan 22;8:10. doi: 10.3389/fnbeh.2014.00010. eCollection 2014.

26.

Resveratrol prevents rapamycin-induced upregulation of autophagy and selectively induces apoptosis in TSC2-deficient cells.

Alayev A, Sun Y, Snyder RB, Berger SM, Yu JJ, Holz MK.

Cell Cycle. 2014;13(3):371-82. doi: 10.4161/cc.27355. Epub 2013 Dec 4.

27.

Synthetic microRNA-mediated downregulation of Nogo-A in transgenic rats reveals its role as regulator of synaptic plasticity and cognitive function.

Tews B, Schönig K, Arzt ME, Clementi S, Rioult-Pedotti MS, Zemmar A, Berger SM, Schneider M, Enkel T, Weinmann O, Kasper H, Schwab ME, Bartsch D.

Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6583-8. doi: 10.1073/pnas.1217665110. Epub 2013 Apr 1.

28.

A functional Tph2 C1473G polymorphism causes an anxiety phenotype via compensatory changes in the serotonergic system.

Berger SM, Weber T, Perreau-Lenz S, Vogt MA, Gartside SE, Maser-Gluth C, Lanfumey L, Gass P, Spanagel R, Bartsch D.

Neuropsychopharmacology. 2012 Aug;37(9):1986-98. doi: 10.1038/npp.2012.46. Epub 2012 Apr 11.

29.

Clinical evaluation of end caps in elastic stable intramedullary nailing of femoral and tibial shaft fractures in children.

Slongo T, Audigé L, Hunter JB, Berger SM.

Eur J Trauma Emerg Surg. 2011 Jun;37(3):305. doi: 10.1007/s00068-011-0091-8. Epub 2011 Mar 19.

PMID:
26815112
30.

Quantitative analysis of conditional gene inactivation using rationally designed, tetracycline-controlled miRNAs.

Berger SM, Pesold B, Reber S, Schönig K, Berger AJ, Weidenfeld I, Miao J, Berger MR, Gruss OJ, Bartsch D.

Nucleic Acids Res. 2010 Sep;38(17):e168. doi: 10.1093/nar/gkq616. Epub 2010 Jul 17.

31.

Rescue Angioplasty in Failed Thrombolysis in Acute Myocardial Infarction: A Community Hospital Experience.

Gorfinkel HJ, Berger SM, Klaus AP, Barresi V V, Shah MR, Graham B, Arn AR, Guinn VL, Phillips M.

J Invasive Cardiol. 1997 Mar;9(2):83-87.

PMID:
10762879
32.

Morphologic observations after percutaneous transluminal balloon angioplasty of early and late aortocoronary saphenous vein bypass grafts.

Waller BF, Rothbaum DA, Gorfinkel HJ, Ulbright TM, Linnemeier TJ, Berger SM.

J Am Coll Cardiol. 1984 Oct;4(4):784-92.

33.

Candidates for transluminal coronary angioplasty.

Berger SM, Gorfinkel HJ.

Am J Cardiol. 1981 Oct;48(4):810. No abstract available.

PMID:
6456659
34.

Conservative management of phantom-limb and amputation-stump pain.

Berger SM.

Ann R Coll Surg Engl. 1980 Mar;62(2):102-5.

35.
36.

Vicarious eyelid conditioning.

Bernal G, Berger SM.

J Pers Soc Psychol. 1976 Jul;34(1):62-8.

PMID:
957101
37.

Some effects of a model's performance on an observer's electromyographic activity.

Berger SM, Hadley SW.

Am J Psychol. 1975 Jun;88(2):263-76.

PMID:
1200186
38.

Letter: Esophagopericardial fistula with survival.

Miller GE, Berger SM.

JAMA. 1974 Feb 25;227(8):939. No abstract available.

PMID:
4405867
39.

Electromyographic activity during observational learning.

Berger SM, Irwin DS, Frommer GP.

Am J Psychol. 1970 Mar;83(1):86-94. No abstract available.

PMID:
5449393
40.

Effect of a model's expressed emotions on an observer's resistance to extinction.

Berger SM, Johansson SL.

J Pers Soc Psychol. 1968 Sep;10(1):53-8. No abstract available.

PMID:
5682524
41.

Unsuspected breast cancers and x-ray microcalcifications.

Gershon-Cohen J, Berger SM, Isard HJ.

J Radiol Electrol Med Nucl. 1967 Nov;48(11):687-93. No abstract available.

PMID:
5591653
42.

Social structure and mediated learning.

Berger SM.

J Pers Soc Psychol. 1967 Sep;7(1):104-8. No abstract available.

PMID:
6052652
43.

Mammographic screening for breast cancer.

Gershon-Cohen J, Ingleby H, Berger SM, Forman M, Curcio BM.

Radiology. 1967 Apr;88(4):663-7. No abstract available.

PMID:
6020928
44.

Breast cancer with microcalcifications: diagnostic difficulties.

Gershon-Cohen J, Berger SM.

Radiology. 1966 Oct;87(4):613-22. No abstract available.

PMID:
5923753
45.

Observer practice and learning during exposure to a model.

Berger SM.

J Pers Soc Psychol. 1966 Jun;3(6):696-701. No abstract available.

PMID:
5939007
46.

A co-operative evaluation of mammography in seven teaching hospitals.

Friedman AK, Askovitz SI, Berger SM, Dodd GD, Fisher MS, Lapayowker MS, Moore JP, Parlee DE, Stein GN, Pendergrass EP.

Radiology. 1966 May;86(5):886-91. No abstract available.

PMID:
5936101
47.

Mammographic localization of unsuspected breast cancer.

Berger SM, Curcio BM, Gershoncohen J, Isard HJ.

Am J Roentgenol Radium Ther Nucl Med. 1966 Apr;96(4):1046-52. No abstract available.

PMID:
5935470
48.

Mammography.

Gershon-Cohen J, Berger SM, Isard HJ.

Obstet Gynecol. 1966 Jan;27(1):102-6. No abstract available.

PMID:
5900638
49.

Mammography: some remarks on techniques.

Gershon-Cohen J, Berger SM, Delpino L.

Radiol Clin North Am. 1965 Dec;3(3):389-401. No abstract available.

PMID:
5846851
50.

Effects of apparent pain in others on observer's reaction time.

Di Lollo V, Berger SM.

J Pers Soc Psychol. 1965 Oct;2(4):573-5. No abstract available.

PMID:
5841363

Supplemental Content

Loading ...
Support Center